Raed Al Rajabi, MD
Internal Medicine · Westwood, KSNPI 1992798839
Payments from drug & device makers
Across 708 payments — averaging $6421.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2.5M
- Merck$720K
- Exelixis Inc.$329K
- Incyte Corporation$242K
- Mirati Therapeutics, Inc.$139K
- Bayer$135K
- plus $524K from 19 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 47 | $2,456,604 |
| Merck | 116 | $720,328 |
| Exelixis Inc. | 120 | $329,135 |
| Incyte Corporation | 286 | $242,162 |
| Mirati Therapeutics, Inc. | 1 | $139,004 |
| Bayer | 5 | $135,318 |
| E.r. Squibb & Sons, L.L.C. | 8 | $98,056 |
| Taiho Oncology, Inc. | 16 | $85,203 |
| Tersera Therapeutics LLC | 27 | $78,585 |
| Array Biopharma Inc | 15 | $73,395 |
| Pfizer | 11 | $38,769 |
| Coherus Oncology, Inc. | 1 | $34,409 |
| EMD Serono, Inc. | 15 | $33,230 |
| Astrazeneca UK Limited | 3 | $29,680 |
| Lexicon Pharmaceuticals, Inc. | 3 | $13,979 |
| Ipsen Biopharmaceuticals, Inc | 7 | $13,330 |
| Sirtex Medical Inc | 13 | $13,293 |
| Deciphera Pharmaceuticals Inc. | 6 | $9,340 |
| Amgen | 1 | $1,500 |
| Eisai Inc. | 1 | $670 |
| Daiichi Sankyo Inc. | 1 | $124 |
| Lilly USA, LLC | 1 | $110 |
| Genentech USA, Inc. | 2 | $57 |
| Novo Nordisk | 1 | $17 |
| Eli Lilly | 1 | $6 |
How this compares
$4,546,304 in reported general payments places this provider in the 95th percentile of 705 internal medicine providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Westwood
- Lauren NyeWestwood$409K
- Martin KankamLeavenworth$63.4M
- Mark HamblinKansas City$5.2M
- Katherine WillinghamTopeka$4.8M
- Leslie SpikesKansas City$4.5M
- Michael CoxTopeka$3.4M
- James RuhlmannHutchinson$2.8M
- Scott TeeterTopeka$1.2M
- Shadi HamdehKansas City$1.1M
- Kyle WorkKansas City$863K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.